menu
    • menu

    Company profile for Zhejiang Hisun Chemical Co., Ltd.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35% of its staff members are technicians. With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field t...
    Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35% of its staff members are technicians. With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field through its sustainable researching, marketing efforts and strong distribution network. The company, with its headquarter located in Taizhou, Zhejiang, now has two wholly-owned subsidiary companies , two Sino-foreign joint ventures and one Provincial Hi-tech R&D Centre. Since it was established, Hisun Chemical has already passed ISO9000 & ISO14000 and gained lots of honors like “First AA-level Credit Enterprise of China Pesticide Industry” and “National Hi-tech Enterprise”, etc. Its product, Abamectin has also gained such awards as ”First Prize of S&T Advance Award of China Chemical Industry”, “Major Achievements in National Technologies R&D Program of the 8th Five-year plan of China” and “ Outstanding Project Award in National Technology Innovation Program of the 8th Five-year of China”. Meanwhile, Hisun Chemical has also undertaken the project of Emamectin Benzoate in National Key Technologies R&D program of the 9th Five-year plan of China. And Ascomycin, a kind of its biofungicides, has been listed in “National S&T Pillar Program of Technical Material Development in the 11th Five-year plan of China.” Based on full implement of EHS system and high quality product, Hisun Chemical has been one of the suppliers to many multinational companies, like Bayer, Syngenta, Boehringer Ingelheim and Cheminova, establishing long term business relationship with them. Hisun Chemical exports 85% of its products, ranging from Insecticides, Herbicides to Fungicides, directly to more than 50 countries over the world. Among those products, its patented products such as Oxine copper 33.5% SC & Flazasulfuron have obtained exclusive registration in China. Hisun Chemical adheres to “For Shareholders, For Staff, For Community” as its management purpose, “Honesty, Innovation, Collaboration& Diligence” as its core values, and “Broad Mind& Integrity” as its spirit. With advanced technology, and R&D, Hisun Chemical will strive to become a representative of Agrochemical, Pharmaceutical &Animal Health Field in the 21st century. Our Group-ZHEJIANG HISUN GROUP The original name of Hisun is HaiMen Pharmaceutical Company founded in 1956 and changed her name at 1997 to Zhejiang Hisun Group. Hisun is located in Taizhou, which is a scenic and coastal city at East Sea in China and is part of the southern tip of Shanghai Economic Zone. It contains 100 hectare area and there are more than 3000 employees. Hisun is ranked in the top 520 key enterprises in China, total asset of Hisun has reached RMB 1.6 billion, there is a national R&D center in Hisun and more than 30% of its staff are technician. Hisun has developed into the largest antibiotic and antineoplastic manufacturer and become a reputed one of main chemical production bases in China. There are three main subsidiary companies under Hisun Group which are Hisun pharmaceutical has been listed in SSE, Hisun Chemical and Hisun thermoelectricity. T products of Hisun have been approved and certified by FDA of U.S.A. meanwhile Hisun have got the approvals of ISO9001, ISO9002 and ISO14000. Hisun exports 80% of its products to approximately 100 countries all over the world, the products performance has been approved by domestic and international consumers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Hisun Chemical Co., Ltd.China Flag
    Country
    Country
    China
    Address
    Address
    No.97 Waisha Road, Jiaojiang District, Taizhou, Zhejiang 318000
    Telephone
    Telephone
    +86 576 88827793
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.hisunchem.com/eabout.asp
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI India

    Not Confirmed

    envelop Contact Supplier

    CPhI India

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    mic“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations  Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support  How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing 

    Impressions: 2113

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/over-500-million-syringes-of-our-hyaluronic-acid-have-been-safely-used-worldwide

    PharmaCompass
    04 Nov 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour API, Our ExpertiseYour API, Our Expertise

    Your API, Our Expertise
    Your API, Our Expertise

    reelYour API, Our Expertise

    This PharmaReel showcases Minakem as a trusted partner for APIs, HPAPIs and steroids from FDA/GMP-certified sites, offering generic & custom solutions and CDMO services from lab to commercial supply, backed by regulatory know-how.

    Impressions: 198

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    The global pharmaceutical excipients market continued to evolve in the third quarter (Q3) of 2025, supported by rising demand for functional excipients, growth in production of generics, and advances in drug delivery technologies. The global market for pharmaceutical excipients was estimated at US$ 9.8 billion to US$ 10.7 billion in 2024, and is projected to grow at a compound annual growth rate (CAGR) of 4.1 to 6.6 percent through 2030. At this pace, the market is expected to reach US$ 13.05 billion to US$ 14.86 billion by 2030. Europe retained the largest market share in 2024, followed by Asia-Pacific. Key drivers shaping the excipients market include the rising prevalence of chronic diseases, expansion of biologics and biosimilars, and increasing quality and regulatory expectations. Increased investments in facility expansions and ongoing reforms in clinical trial regulations are also facilitating market growth. The sector remains highly competitive and fragmented. Major excipient providers include BASF, Roquette, Gangwal Healthcare, DuPont, Evonik, Seqens, SPI Pharma, PMC Isochem, Croda International, Pfanstiehl, Colorcon, Kewpie Corporation, ICE Pharma, Nanjing Well Pharmaceutical, Merck KGaA owned MilliporeSigma, Minakem, Ashland Global, Actylis and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)  Evonik in partnership with Ethris; Colorcon Ventures invests in Phytolon   The market saw strategic collaborations across the excipients and drug formulation ecosystem in Q3 2025. Evonik entered into a partnership with Ethris to strengthen its nucleic acid delivery platform. The collaboration integrates Ethris’ proprietary technology — its lipidoid nanoparticle platform, known as SNaP LNP — into Evonik’s CDMO offerings, enhancing the latter’s ability to support RNA-based therapeutics from concept to clinic. Colorcon Ventures, the investment arm of Colorcon, announced a strategic investment in Israel-based Phytolon. The biotechnology start-up uses precision fermentation to develop natural colorants. The investment underscores Colorcon’s commitment to next-generation coloring technologies that support cleaner-label formulations and innovation in oral solid dosage coatings.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Evonik launches MaxiPure Polysorbate 80; Asahi Kasei expands its portfolio The quarter saw continued innovation in high-purity and injectable-grade excipients. Evonik introduced MaxiPure Polysorbate 80, a high-purity injectable-grade surfactant designed for biologics and parenteral formulations. This excipient addresses key challenges such as protein stability, viral inactivation, and the solubilization of hydrophobic APIs, while meeting regulatory expectations across global markets. Asahi Kasei expanded its Sonanos portfolio of excipients with two new products — Sonanos PG (optimized for sustained release of biologics and peptides while supporting patient-friendly dosing)  and Sonanos DS (developed to enhance solubility of poorly water-soluble APIs). These additions reflect growing industry demand for dosage optimization, stability, and specialized delivery of complex molecules. Gangwal Healthcare operates EXCiPACT-certified GMP facilities and offers a broad range of functional excipients, including co-processed blends like ProBlend, Starlose, and Microlose. Its excipients, including Solvostar (sodium starch glycolate) and Sallyso (croscarmellose sodium), support enhanced tablet disintegration and drug release. The company also provides taste-masking agents such as SucreX (sucralose) and CutCal (neotame), supporting the development of patient-friendly oral dosage forms.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Colorcon, Gattefossé, Croda, Roquette, Clariant expand manufacturing capacities Manufacturing investments and facility expansions remained a key trend during Q3 2025. Colorcon inaugurated a new state-of-the-art, film coating manufacturing facility in Johor, Malaysia. The site incorporates energy-efficient systems and advanced production technologies to strengthen Colorcon’s functional-excipient supply network across Asia. Gattefossé opened a new lipid-based excipient facility in Texas (US), marking a strategic expansion of its North American manufacturing footprint. Croda International expanded its Leek, UK facility with a lipid system synthesis unit and enhanced R&D capabilities. The site will support the launch of Super Refined Poloxamer 188, a highly purified fast-dissolving granular excipient. Roquette announced the opening of a dedicated innovation center in São Paulo, Brazil, strengthening its engagement with regional drug developers. Clariant expanded its Daya Bay, China facility, adding a second spray tower dedicated to pharmaceutical excipient production. The upgraded site increases capacity for excipients used in laxatives and other formulations. BASF also strengthened its commitment to biopharma and pharmaceutical ingredients with a new GMP Solution Center in Michigan (US). The facility expands BASF’s network of poloxamer (a synthetic polymer) manufacturing sites. With state-of-the-art clean room packaging and high-sensitivity analytical testing, this new facility will enable close collaboration with BASF’s customers on customized chemistries for product development.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   India mandates excipient disclosure; new rules to apply from March 2026  India has made it mandatory to disclose excipient details from March 2026 under the country’s new Drugs (2nd Amendment) Rules, 2025. This applies to Schedule H2 medicines. The final notification expands earlier draft requirements by mandating qualitative excipient details in QR codes on product packaging. This should enhance transparency and support patient safety. Meanwhile, US pharmaceutical groups have responded to the US Food and Drug Administration’s draft guidance proposing simplified pathways for replacing color additives in drug products. Industry associations have supported draft guidance, noting that it reduces regulatory burden while maintaining product quality and consistency.  View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)   Our view While the fast-growing generics market is creating demand for cost-effective and versatile excipients, the market is also witnessing innovations tailored to the specialized needs of biologics and biosimilars. India is poised to become a key player in the global excipient market, supported by the rapid growth in its generic drug industry, expansion of its health infrastructure and increasing investments in R&D. The new excipient-disclosure rules, therefore, are likely to benefit the global excipient industry by improving transparency and strengthening quality ecosystems.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 316

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-evonik-launches-high-purity-excipients-india-mandates-disclosures-from-march-2026

    #PharmaFlow by PHARMACOMPASS
    20 Nov 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    China's Zhejiang Hisun picks up new U.S. deal despite FDA troubles
    China's Zhejiang Hisun picks up new U.S. deal despite FDA troubles

    11 Aug 2016

    // Eric Palmer FIERCE PHARMA

    http://www.fiercepharma.com/manufacturing/china-s-troubled-zhejiang-hisun-keeps-picks-up-new-u-s-business

    Eric Palmer FIERCE PHARMA
    11 Aug 2016
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    31139-87-4

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    31139-87-4

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 217MF10347

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2005-07-27

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    4-Biphenylacetic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    4-Biphenylacetic Acid

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 217MF10345

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2005-07-27

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Biotin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Biotin

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 217MF10344

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2005-07-27

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Bisbentiamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Bisbentiamine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 217MF10346

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2005-07-27

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Candesartan Cilexetil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Candesartan Cilexetil

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 225MF10116

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2013-06-11

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Escitalopram Oxalate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Escitalopram Oxalate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 303MF10122

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2021-08-02

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Polaprezinc

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Polaprezinc

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 223MF10167

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2011-12-05

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Procainamide Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    Procainamide Hydrochloride

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 218MF10970

    Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture

    Initial Date of Registration : 2006-12-01

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Anastrozole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow

    10

    Bicalutamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI India
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Zhejiang Hisun Chemical Co., Ltd and get a quotation

    Zhejiang Hisun Chemical Co., Ltd is a supplier offers 74 products (APIs, Excipients or Intermediates).

    Find a price of 31139-87-4 bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of 4-Biphenylacetic Acid bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Biotin bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Bisbentiamine bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Candesartan Cilexetil bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Escitalopram Oxalate bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Polaprezinc bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Procainamide Hydrochloride bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Acarbose bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Ademetionine 1,4-Butanedisulfonate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Ademetionine Disulfate Tosylate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Adenosine bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Anastrozole bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Apixaban bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Apremilast bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Aripiprazole bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Bedaquiline bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Bicalutamide bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Bleomycin Sulphate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Cladribine bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Cyclophosphamide bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Cytarabine bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Dactinomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Daptomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Daunorubicin HCl bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Donepezil bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Doxorubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Eltrombopag bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Emodepside bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Epirubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Eprinomectin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Everolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Fipronil bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Fludarabine Phosphate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Fluralaner bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Fluvastatin Sodium bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Glutathione bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Idarubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Imidacloprid bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Imipenem + Cilastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Immunomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Isepamicin Sulfate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Ivermectin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Letrozole bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Linezolid bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Lovastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Lurasidone Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Meropenem bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Mesna bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Methoprene bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Micafungin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Milbemycin Oxime bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Minocycline Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Mitomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Moxidectin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Mycophenolate Mofetil bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Mycophenolic Acid bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Orlistat bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Oseltamivir Phosphate bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Pirarubicin HCl bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Pravastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Praziquantel bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Pyrroloquinoline Quinone Disodium bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Rifamycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Selamectin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Simvastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Sirolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Tacrolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Tazobactam Sodium bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Teicoplanin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Ticagrelor bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Tigecycline bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Find a price of Tulathromycin bulk offered by Zhejiang Hisun Chemical Co., Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search